December 15, 2020
The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the first COVID-19 diagnostic test that can be completed at home […]
December 15, 2020
The US Food and Drug Administration (FDA) has approved a shorter infusion time for ocrelizumab (Ocrevus) for patients with relapsing or primary progressive multiple sclerosis (MS), […]
December 12, 2020
Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The US Food and Drug Administration (FDA) has authorized Pfizer/BioNTech’s COVID-19 vaccine for emergency use […]
December 11, 2020
The Food and Drug Administration’s new indication for liraglutide (Saxenda) for weight loss in adolescents with obesity, announced on Dec. 4, received welcome as a milestone […]
December 4, 2020
The US Food and Drug Administration (FDA) is reminding clinicians about the need for “at least yearly, lifelong follow-up” to monitor for type III endoleaks in […]
November 26, 2020
The US Food and Drug Administration (FDA) has granted accelerated approval for a new drug for certain patients with neuroblastoma based on response rate results in small open-label […]
November 25, 2020
The US Food and Drug Administration (FDA) has expanded the indication for the antiviral baloxavir marboxil (Xofluza) to include postexposure prophylaxis of uncomplicated influenza in people […]
November 24, 2020
The US Food and Drug Administration (FDA) has approved lumasiran (Oxlumo, Alnylam Pharmaceuticals) subcutaneous injection to treat children and adults with primary hyperoxaluria type 1 (PH1), […]
November 23, 2020
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The FDA issued an emergency use authorization to Regeneron Pharmaceuticals for its […]